All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dr.rajivsantosham on Instagram · 60s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @dr.rajivsantosham's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00TRT this is a new trending topic in bodybuilding and in the fitness industry. TRT are testosterone replacement
  2. 0:06therapy into their Nana low dose testosterone given to people who have low testosterone for example
  3. 0:13people in their 40s and above or people. Romanal, anabolic, xeraj, jus, ponita, natural testosterone,
  4. 0:19drapanaguluk, kudupana. Indian napanano it improves their health, improves their heart health,
  5. 0:24improves muscle, mass bone density etc. Who should give you TRT? A doctor who knows about
  6. 0:30testosterone, a doctor who knows the side effects of using these hormones and a doctor who can
  7. 0:35interpret your blood values because you use testosterone. In the TRT in Nana low dose,
  8. 0:40namaku, wadamuk and nariya benefit kudu. TRT is also the most abused term in fitness industry.
  9. 0:45Adao de, TRT, TRT in Solitre, ure amatas de, nariya pare ponita, jahaha.
  10. 0:50Now TRT is a rakan solitre, 125 mg per week average adhicama, 500 mg, 1000 mg
  11. 0:56per week average adhicama, 10 mg per week average adhicama, 10 mg per week average adhicama.

@dr.rajivsantosham's TRT dose claims, fact-checked

Rajiv Santosham

Instagram creator

14.8K viewsView on Instagram

Quick answer

The video addresses testosterone replacement therapy for hypogonadism, touching on appropriate indications (clinically low testosterone in middle-aged men), the importance of physician oversight and blood value interpretation, and the misuse of the TRT label to describe supraphysiological dosing in fitness contexts. The creator correctly identifies physician-supervised dosing and monitoring as non-negotiable, but the claim that TRT broadly improves heart health conflicts with the nuanced cardiovascular safety profile revealed in recent large-scale trials including TRAVERSE (2023). The dose figures cited (125 mg as representative TRT, versus 500 to 1,000 mg as abuse) are directionally accurate but presented without clinical context around formulation, goals, or individual variability.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @dr.rajivsantosham's TRT dose claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@dr.rajivsantosham's TRT dose claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@dr.rajivsantosham's TRT dose claims, fact-checked" from Rajiv Santosham. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video addresses testosterone replacement therapy for hypogonadism, touching on appropriate indications (clinically low testosterone in middle-aged men), the importance of physician oversight and blood value interpretation, and the misuse of the TRT label to describe supraphysiological dosing in fitness contexts.

The reason this review is not generic is the source wording and the canonical claim label "trt trt the hottest topic in the fitness world right now." In this clip, the useful excerpt is: "TRT this is a new trending topic in bodybuilding and in the fitness industry." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Clinical hypogonadism requires at least two confirmed low morning testosterone readings plus symptoms, per AUA guidelines.
People who land here are usually comparing the Testosterone claim with TRT, FitnessFacts, and BodybuildingTruth.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video addresses testosterone replacement therapy for hypogonadism, touching on appropriate indications (clinically low testosterone in middle-aged men), the importance of physician oversight and blood value interpretation, and the misuse of the TRT label to describe supraphysiological dosing in fitness contexts.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video addresses testosterone replacement therapy for hypogonadism, touching on appropriate indications (clinically low testosterone in middle-aged men), the importance of physician oversight and blood value interpretation, and the misuse of the TRT label to describe supraphysiological dosing in fitness contexts. The creator correctly identifies physician-supervised dosing and monitoring as non-negotiable, but the claim that TRT broadly improves heart health conflicts with the nuanced cardiovascular safety profile revealed in recent large-scale trials including TRAVERSE (2023). The dose figures cited (125 mg as representative TRT, versus 500 to 1,000 mg as abuse) are directionally accurate but presented without clinical context around formulation, goals, or individual variability.
  • The TRAVERSE trial (Lincoff et al., 2023, NEJM) found TRT did not increase heart attacks or strokes in high-risk men, but did raise rates of atrial fibrillation and pulmonary embolism, making cardiovascular effects a mixed picture, not a clear benefit.
  • Clinical hypogonadism requires at least two confirmed low morning testosterone readings plus symptoms, per AUA guidelines. Age alone or fitness goals do not qualify someone for treatment.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The TRAVERSE trial (Lincoff et al., 2023, NEJM) found TRT did not increase heart attacks or strokes in high-risk men, but did raise rates of atrial fibrillation and pulmonary embolism, making cardiovascular effects a mixed picture, not a clear benefit.
  • Clinical hypogonadism requires at least two confirmed low morning testosterone readings plus symptoms, per AUA guidelines. Age alone or fitness goals do not qualify someone for treatment.
  • Bhasin et al. (1996, NEJM) confirmed testosterone increases muscle mass dose-dependently, but these gains were studied in the context of hypogonadism, not general optimization in men with normal testosterone.
  • The creator's framing of 500 to 1,000 mg per week as abuse of the TRT label is directionally correct. Doses that high are supraphysiological by any clinical definition and carry substantially higher cardiovascular and hematological risk.
  • Testosterone therapy suppresses the hypothalamic-pituitary-gonadal axis, reducing or eliminating natural testosterone production and sperm output. Rahnema et al. (2014, Fertility and Sterility) documented that recovery is not guaranteed after prolonged use.
  • Hematocrit monitoring is required during TRT because elevated red blood cell mass increases clotting risk. This is a non-negotiable part of any responsible protocol and was not mentioned in the video.
  • The Endocrine Society (Bhasin et al., 2018) recommends against initiating TRT in men who want to preserve fertility, as exogenous testosterone suppresses sperm production in a majority of users.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dr.rajivsantosham actually say?

The creator made several specific claims about testosterone replacement therapy: that it's meant for men with low testosterone (typically those in their 40s or long-term steroid users), that it should be prescribed by a doctor who understands blood values and side effects, and that it improves heart health, muscle mass, and bone density. Then the video takes a harder turn.

The creator argues that TRT is "the most abused term in fitness industry," suggesting that what gets called TRT in fitness circles is actually closer to a steroid cycle. They implied that real TRT sits around 125 mg per week, while what bodybuilders actually use runs to 500 mg or even 1,000 mg per week, framing those higher doses as a misuse of the TRT label. That distinction, if accurately communicated, is the most clinically useful thing in this video.

Does the science back this up?

On the core physiology, yes, largely. The claim that TRT improves bone density and muscle mass in hypogonadal men is well-supported. The heart health claim is more complicated and deserves more nuance than this video offered.

Bone density benefits are documented. A 2006 meta-analysis by Tracz et al. in the Journal of Clinical Endocrinology and Metabolism found that testosterone therapy in hypogonadal men significantly improved lumbar spine bone mineral density. Muscle mass improvements are similarly established, with Bhasin et al. (1996, NEJM) demonstrating dose-dependent increases in fat-free mass with testosterone administration.

Cardiovascular effects are where the science gets messier. The creator said TRT "improves heart health," which is an oversimplification. The TRAVERSE trial (Lincoff et al., 2023, NEJM) found testosterone replacement did not increase major adverse cardiovascular events in hypogonadal men with high cardiovascular risk, but it also found elevated rates of atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group. "Improves heart health" is not how most cardiologists would characterize those findings.

What did they get wrong (or right)?

Credit where it's due: the creator is correct that the term TRT is widely misapplied in fitness communities. That's accurate, and saying it publicly takes some nerve given the audience likely includes people doing exactly that.

The 125 mg per week figure cited as a typical TRT dose is plausible but presented without context. Clinically, testosterone replacement doses vary by formulation, route of administration, and individual pharmacokinetics. Injectable testosterone cypionate or enanthate in a true replacement protocol typically ranges from 50 mg to 200 mg per week, with the goal of restoring serum testosterone to a physiological range, usually 400 to 700 ng/dL. The creator's framing of 125 mg as a single benchmark is a rough approximation, not a clinical standard, and presenting it as the dividing line between therapy and abuse oversimplifies how dosing decisions are actually made.

The cardiovascular claim is the biggest unforced error here. Saying TRT "improves heart health" without qualification is misleading given the current evidence base. A doctor presenting this information to patients should know better.

What should you actually know?

TRT is a legitimate medical treatment for clinically confirmed hypogonadism, defined by consistently low serum testosterone levels combined with symptoms. It is not a general wellness upgrade or a legal workaround for performance enhancement. The distinction the creator draws between real TRT and high-dose testosterone use is real and worth understanding.

If you're considering TRT, the diagnostic standard matters. The American Urological Association recommends confirming low testosterone with at least two morning fasting blood draws before initiating therapy. Symptoms alone are not sufficient justification for treatment. You also need baseline hematocrit, PSA, and cardiovascular risk assessment.

Monitoring during treatment is not optional. Testosterone therapy raises hematocrit, which increases clotting risk. It suppresses endogenous testosterone production and can reduce sperm count, sometimes irreversibly with prolonged use. Anyone presenting TRT as a simple health optimization tool without mentioning these trade-offs is leaving out the part that matters most to your long-term health.

  • Confirmed hypogonadism requires laboratory evidence, not just symptoms or age
  • Cardiovascular effects of TRT are mixed, not uniformly positive
  • High-dose testosterone use in bodybuilding is pharmacologically different from medical TRT
  • Fertility effects can be long-lasting and should be discussed before starting treatment
  • Any TRT protocol requires ongoing monitoring of blood counts, hormone levels, and cardiovascular markers

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Rajiv Santosham · Instagram creator

14.8K views on this video

💉 TRT – The hottest topic in the fitness world right now! Testosterone Replacement Therapy is meant for those with low T-levels – usually men in their 40s or long-term steroid users. ✅ Done right (

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the traverse trial (lincoff et al., 2023, nejm) found trt?

The TRAVERSE trial (Lincoff et al., 2023, NEJM) found TRT did not increase heart attacks or strokes in high-risk men, but did raise rates of atrial fibrillation and pulmonary embolism, making cardiovascular effects a mixed picture, not a clear benefit.

What does the video say about clinical hypogonadism requires at least two confirmed low morning testosterone?

Clinical hypogonadism requires at least two confirmed low morning testosterone readings plus symptoms, per AUA guidelines. Age alone or fitness goals do not qualify someone for treatment.

What does the video say about bhasin et al. (1996, nejm) confirmed testosterone increases muscle mass?

Bhasin et al. (1996, NEJM) confirmed testosterone increases muscle mass dose-dependently, but these gains were studied in the context of hypogonadism, not general optimization in men with normal testosterone.

What does the video say about the creator's framing of 500 to 1,000 mg per week?

The creator's framing of 500 to 1,000 mg per week as abuse of the TRT label is directionally correct. Doses that high are supraphysiological by any clinical definition and carry substantially higher cardiovascular and hematological risk.

What does the video say about testosterone therapy suppresses the hypothalamic-pituitary-gonadal axis, reducing?

Testosterone therapy suppresses the hypothalamic-pituitary-gonadal axis, reducing or eliminating natural testosterone production and sperm output. Rahnema et al. (2014, Fertility and Sterility) documented that recovery is not guaranteed after prolonged use.

What does the video say about hematocrit monitoring?

Hematocrit monitoring is required during TRT because elevated red blood cell mass increases clotting risk. This is a non-negotiable part of any responsible protocol and was not mentioned in the video.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Rajiv Santosham, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.